NEWS & EVENTS

Successful FDA inspection of Alpex Pharma cGMP

Alpex Pharma was inspected for cGMP regulations in August 2015, and the outcome once more was satisfactory. There was...

Read more

R&D Projects

R&D Projects

Alpex Pharma has undertaken extensive development activities for third parties.
It also identifies product opportunities and develops them internally in view of finding interested licensing partners.
Our development plan include drug-excipient compatibility studies, analytical method development, definition of formula, cleaning development, non-pivotal stability studies and reporting.

Projects currently under developement

Alpex ID Code # A166
Drug category: Mucolythic Prescription: OTC
Dosage form: Effervescent tablets License granted: Available
Indication: Cold and Cought Free available territories: Worldwide
Alpex ID Code # A153
Drug category: NSAID Prescription: RX
Dosage form: ODT License granted: Few EU & Asian Counties
Indication: Artritis Reumatoide Free available territories: Rest of the world
Alpex ID Code # A152
Drug category: Benzodiazepine Prescription: RX
Dosage form: ODT License granted: USA
Indication: Seizure Disorders & Panic Disorders Free available territories: Rest of the World
Alpex ID Code # A135
Drug category: Narcotic Prescription: RX
Dosage form: ODT License granted: USA
Indication: Breakthrough Pain (buccal) Free available territories: Rest of the World
Page: 1 2 ... >